JP2006504737A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2006504737A5 JP2006504737A5 JP2004543233A JP2004543233A JP2006504737A5 JP 2006504737 A5 JP2006504737 A5 JP 2006504737A5 JP 2004543233 A JP2004543233 A JP 2004543233A JP 2004543233 A JP2004543233 A JP 2004543233A JP 2006504737 A5 JP2006504737 A5 JP 2006504737A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- chromeno
- difluoro
- quinoline
- dihydro
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US41796802P | 2002-10-11 | 2002-10-11 | |
| PCT/US2003/024420 WO2004033461A1 (en) | 2002-10-11 | 2003-08-04 | 5-SUBSTITUTED 7,9-DIFLUORO-5H-CHROMENO[3,4-f]QUINOLINE COMPOUNDS AS SELECTIVE PROGESTERONE RECEPTOR MODULATORS |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2006504737A JP2006504737A (ja) | 2006-02-09 |
| JP2006504737A5 true JP2006504737A5 (https=) | 2006-09-21 |
Family
ID=31994318
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004543233A Pending JP2006504737A (ja) | 2002-10-11 | 2003-08-04 | 選択的プロゲステロン受容体モジュレーターとしての５−置換７，９−ジフルオロ−５Ｈ−クロメノ［３，４−ｆ］キノリン化合物 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US7163946B2 (https=) |
| EP (1) | EP1554283A1 (https=) |
| JP (1) | JP2006504737A (https=) |
| AR (1) | AR040781A1 (https=) |
| AU (1) | AU2003258051A1 (https=) |
| CA (1) | CA2501834A1 (https=) |
| CL (1) | CL2003001545A1 (https=) |
| DE (1) | DE20301728U1 (https=) |
| HK (1) | HK1055059A2 (https=) |
| MX (1) | MXPA05003801A (https=) |
| TW (1) | TW200413384A (https=) |
| WO (1) | WO2004033461A1 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6566372B1 (en) | 1999-08-27 | 2003-05-20 | Ligand Pharmaceuticals Incorporated | Bicyclic androgen and progesterone receptor modulator compounds and methods |
| US7026484B2 (en) * | 2001-02-23 | 2006-04-11 | Ligand Pharmaceuticals Incorporated | Tricyclic androgen receptor modulator compounds and methods |
| AU2003258047A1 (en) | 2002-10-11 | 2004-05-04 | Ligand Pharmaceuticals Incorporated | 5-(1',1'-CYCLOALKYL/ALKENYL)METHYLIDENE 1,2-DIHYDRO-5H-CHROMENO(3,4-f)QUINOLINES AS SELECTIVE PROGESTERONE RECEPTOR MODULATOR COMPOUNDS |
| AR040782A1 (es) | 2002-10-11 | 2005-04-20 | Ligand Pharm Inc | Derivados de 5- cicloalquenil-5h- cromeno [ 3,4- f] quinolina como compuestos mudulares selectivos de receptores de progesterona |
| DE20301728U1 (de) | 2002-10-11 | 2004-03-11 | Ligand Pharmaceuticals, Inc., San Diego | 5-substituierte 7,9-Difluor-5H-Chromeno(3,4-f) -Chinolin-Verbindungen als selektive Progesteronrezeptormodulator-Verbindungen |
| MD3820874T2 (ro) * | 2018-07-12 | 2023-05-31 | Lilly Co Eli | Degradanți selectivi ai receptorului estrogen |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3635941A (en) * | 1969-04-01 | 1972-01-18 | Eastman Kodak Co | Disperse mono azo dyes containing an acylamidotetrahydroquinoline group |
| US3907507A (en) * | 1971-04-26 | 1975-09-23 | Heliodoro Monroy Rivera | Novel apparatus for the obtention of substituted 1,2-dihydroquinolines |
| DK0934937T3 (da) | 1990-11-30 | 2002-04-02 | Otsuka Pharma Co Ltd | Azolderivater som superoxidradikalinhibitor |
| JPH04316557A (ja) | 1991-04-16 | 1992-11-06 | Kyorin Pharmaceut Co Ltd | ６−アリール環状アントラニル酸誘導体 |
| US5506102A (en) * | 1993-10-28 | 1996-04-09 | Ligand Pharmaceuticals Incorporated | Methods of using the A form of the progesterone receptor to screen for antagonists of steroid intracellar receptor-mediated transcription |
| EP1043325B1 (en) | 1994-12-22 | 2004-06-16 | Ligand Pharmaceuticals Incorporated | Steroid receptor modulator compounds and methods |
| US5696127A (en) * | 1994-12-22 | 1997-12-09 | Ligand Pharmaceuticals Incorporated | Steroid receptor modulator compounds and methods |
| US6696459B1 (en) * | 1994-12-22 | 2004-02-24 | Ligand Pharmaceuticals Inc. | Steroid receptor modulator compounds and methods |
| JP2000513362A (ja) | 1996-06-27 | 2000-10-10 | リガンド・ファーマスーティカルス・インコーポレーテッド | アンドロゲン受容体モジュレーター化合物及び方法 |
| DE69904804T2 (de) * | 1998-02-13 | 2003-11-06 | Abbott Laboratories, Abbott Park | Glucocorticoid selektive entzündungshemmende mittel |
| US6506766B1 (en) * | 1998-02-13 | 2003-01-14 | Abbott Laboratories | Glucocortiocoid-selective antinflammatory agents |
| US6380207B2 (en) * | 1998-02-13 | 2002-04-30 | Abbott Laboratories | Glucocortiocoid-selective antiinflammatory agents |
| US6093826A (en) * | 1998-06-08 | 2000-07-25 | Ligand Pharmaceuticals Incorporated | Process for the preparation of C(5)-substituted 1,2-dihydro-5H-chromeno[3,4-f] quinolines |
| DE20301728U1 (de) | 2002-10-11 | 2004-03-11 | Ligand Pharmaceuticals, Inc., San Diego | 5-substituierte 7,9-Difluor-5H-Chromeno(3,4-f) -Chinolin-Verbindungen als selektive Progesteronrezeptormodulator-Verbindungen |
| AR040782A1 (es) * | 2002-10-11 | 2005-04-20 | Ligand Pharm Inc | Derivados de 5- cicloalquenil-5h- cromeno [ 3,4- f] quinolina como compuestos mudulares selectivos de receptores de progesterona |
| AU2003258047A1 (en) * | 2002-10-11 | 2004-05-04 | Ligand Pharmaceuticals Incorporated | 5-(1',1'-CYCLOALKYL/ALKENYL)METHYLIDENE 1,2-DIHYDRO-5H-CHROMENO(3,4-f)QUINOLINES AS SELECTIVE PROGESTERONE RECEPTOR MODULATOR COMPOUNDS |
-
2003
- 2003-02-04 DE DE20301728U patent/DE20301728U1/de not_active Expired - Lifetime
- 2003-08-04 AR AR20030102794A patent/AR040781A1/es not_active Application Discontinuation
- 2003-08-04 CA CA002501834A patent/CA2501834A1/en not_active Abandoned
- 2003-08-04 MX MXPA05003801A patent/MXPA05003801A/es unknown
- 2003-08-04 HK HK03105598A patent/HK1055059A2/xx not_active IP Right Cessation
- 2003-08-04 TW TW092121283A patent/TW200413384A/zh unknown
- 2003-08-04 WO PCT/US2003/024420 patent/WO2004033461A1/en not_active Ceased
- 2003-08-04 CL CL200301545A patent/CL2003001545A1/es unknown
- 2003-08-04 AU AU2003258051A patent/AU2003258051A1/en not_active Abandoned
- 2003-08-04 JP JP2004543233A patent/JP2006504737A/ja active Pending
- 2003-08-04 EP EP03808052A patent/EP1554283A1/en not_active Withdrawn
- 2003-10-10 US US10/684,212 patent/US7163946B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN107485612B (zh) | 咪唑并吡啶化合物及其用途 | |
| ES2568015T3 (es) | Derivado de pirazoloquinolina como inhibidores de PDE9 | |
| JP2005529089A5 (https=) | ||
| EP2655367A1 (en) | N-substituted azetidine derivatives | |
| RS57106B1 (sr) | Derivati benzotiofena i njihove kompozicije kao selektivni degraderi estrogenskog receptora | |
| JP2008530030A (ja) | 新規なチューブリン重合阻害剤 | |
| WO2008021337A1 (en) | Oxazinan-2-one derivatives useful as pr modulators | |
| BR112015004637B1 (pt) | Derivados de imidazolina, seus usos e seus processos de preparação, e composição farmacêutica | |
| TW200536849A (en) | Substituted heterocycles and the uses thereof | |
| JP2015178458A (ja) | ベンゼン環縮合含窒素５員複素環式化合物、またはその薬理学的に許容される塩 | |
| KR20130098269A (ko) | 테트라히드로카르볼린 유도체 | |
| HK1223355A1 (zh) | 作为ep4配体的苯并咪唑衍生物 | |
| WO2023207556A1 (zh) | Prmt5-mta抑制剂 | |
| JP2021508318A (ja) | チューブリン阻害剤 | |
| CN111511736B (zh) | 含氮6元环化合物 | |
| WO2008021339A2 (en) | Pyrrolidine and related derivatives useful as pr modulators | |
| CA2660166C (fr) | Nouveaux derives imidazolones, leur preparation a titre de medicaments, compositions pharmaceutiques, utilisation comme inhibiteurs de proteines kinases notamment cdc7 | |
| CN113518779B (zh) | 噻吩并杂环类衍生物、其制备方法及其在医药上的应用 | |
| JP2022515890A (ja) | エストロゲン受容体タンパク質分解薬 | |
| WO2011013624A1 (ja) | インドール誘導体、またはその薬理学的に許容される塩 | |
| CA3104956A1 (en) | Novel lxr modulators with bicyclic core moiety | |
| JP2006504737A5 (https=) | ||
| CN112125902A (zh) | 一种选择性抑制激酶化合物及其用途 | |
| CN118922185A (zh) | 作为trpa1抑制剂的n3-取代的尿嘧啶化合物 | |
| CN113692276A (zh) | Nurr1受体调节剂 |